3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
4
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
13
Endometrial Neoplasms
2
Carcinoma, Ductal, Breast
2
Peritoneal Neoplasms
1
Fallopian Tube Neoplasms
1
Cystadenocarcinoma, Serous
1
Carcinoma, Lobular
1
Breast Neoplasms, Male
1
Breast Neoplasm Female
1
Breast Carcinoma In Situ
1
Breast Cancer Invasive Nos
1
Advanced, Persistent, or Recurrent Endometrial Cancer
1
Interventions
Tamoxifen
4
Radiotherapy
2
Medroxyprogesterone
2
Chemotherapy, Adjuvant
2
Watchful Waiting
1
Risedronic Acid
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Interviews as Topic
1
Estrogens, Conjugated (USP)
1
Decision Support Techniques
1
Cholecalciferol
1
Celecoxib
1
Brachytherapy
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Breast Carcinoma In Situ
×
Letrozole
×
Clear all
NCT00004205
2017-12-12
BIG 1-98
ETOP IBCSG Partners Foundation
Phase 3
Completed
8,028 enrolled